Antiretroviral therapy in developing countries: pharmacologic considerations
Loading...
Date
2008
Journal Title
Journal ISSN
Volume Title
Publisher
Current Opinion in HIV and AIDS
Abstract
The roll-out of antiretroviral drugs in developing countries has become the largest and most ambitious pharmacology project in history. About 2 million people in developing countries now have access to life-saving antiretrovirals, approximately 28% of those in need [1]. Among treated patients, comparable response rates to those seen in western countries have been demonstrated in the first few years of antiretroviral therapy [2]. It is important to sustain these successes by the efficient use of acceptable, efficacious and minimally toxic regimens.
Description
Keywords
Anti-HIV agents, Developing countries, Drug interactions, Pharmacokinetics, Toxicity
Citation
Lamorde, M., Byakika-Kibwika, P., & Merry, C. (2008). Antiretroviral therapy in developing countries: pharmacologic considerations. Current Opinion in HIV and AIDS, 3(3), 252-257.